(1)
Influences of SGLT2 Inhibitors on the Cardiovascular System of Patients With Type 2 Diabetes Mellitus: An Integrative Review. RSD 2022, 11 (16), e172111638091. https://doi.org/10.33448/rsd-v11i16.38091.